John Bui

John Bui has extensive work experience in the field of drug metabolism and pharmacokinetics (DMPK). John started their career at Exelixis as a Research Associate in 2008, where they worked until 2012. John then joined Onyx Pharmaceuticals, Inc. (an Amgen subsidiary) as a Senior Research Associate in DMPK, from June 2012 to January 2016. John further advanced their career at Gilead Sciences, where they served as a Senior Research Associate II from April 2016 to August 2019. Currently, John is employed at Maze Therapeutics, where they initially joined as a Scientist I in DMPK in August 2019, and later advanced to the position of Scientist II in August 2022.

John Bui attended San Francisco State University from 2000 to 2005. No degree or field of study were specified.